Key Market Indicators
Sales of Greek antirheumatic medicine are forecast to total $45.32 million by 2026, a decrease of 6% annually from 2021's $66.11 million. Since 2003, the Greek market has been declining at a rate of 2.1% each year. The country ranked 12th in 2021, with Chile taking the top spot at $66.11 million. Germany, Spain and Canada followed in second, third and fourth place respectively.
